title: [Is Crohn's disease an indication for growth hormone treatment?].
abstract: In this review we discuss contemporary opinions about the Leśniowski-Crohn disease in particular hormonal abnormalities including growth hormone resistance and the role of adipocytokines. The place of growth hormone in the treatment of chronic inflammatory bowel disease was also discussed.
authors.affiliation: Oddział Endokrynologiczno-Diabetologiczny Wojewódzkiego Specjalistycznego Szpitala Dzieciecego w Kielcach, Kielce. mszalecki@wp.pl
authors.forename: Mieczysław
authors.initials: M
authors.lastname: Szalecki
authors.forename: Katarzyna
authors.initials: K
authors.lastname: Ziora
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D003424:Crohn Disease / Q000150:complications* / Q000188:drug therapy* / Q000378:metabolism; D006130:Growth Disorders / Q000209:etiology / Q000628:therapy*; D019382:Human Growth Hormone / Q000378:metabolism / Q000627:therapeutic use*; D006801:Humans; D000069285:Infliximab; D017526:Receptor, IGF Type 1; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D019382:Human Growth Hormone; D000069285:Infliximab; D017526:Receptor, IGF Type 1